The Patent Finder

Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor

Pharmacyclics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 62/193,518, filed Jul 16, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,655,857Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
US 10,010,507Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 10,213,386Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Low confidence
Pharmacyclics LLCIn force
Low confidence
US 10,828,259Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Low confidence
Pharmacyclics LLCIn force
Low confidence
US 12,551,448Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
In force
 · Low confidence
Pharmacyclics LLCIn force
Low confidence
Application 15/467,414Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
Abandoned
Abandoned Jan 26, 2018
Pharmacyclics LLCAbandonedAbandoned Jan 26, 2018
Application 16/128,312Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
Abandoned
Abandoned Sep 25, 2019
Pharmacyclics LLCAbandonedAbandoned Sep 25, 2019
Application 16/228,682Pharmaceutical Formulations of a Brutons Tyrosine Kinase Inhibitor
Abandoned
Abandoned Sep 15, 2019
Pharmacyclics LLCAbandonedAbandoned Sep 15, 2019
Application 17/536,701Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
Abandoned
Abandoned Nov 14, 2024
Pharmacyclics LLCAbandonedAbandoned Nov 14, 2024
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited